Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 2, 2004New England Journal of Medicine

Obesity and the Metabolic Syndrome in Children and Adolescents

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does increasing severity of obesity increase the prevalence of the metabolic syndrome and adverse cardiovascular biomarkers in children and adolescents?

Population

490 children and adolescents (439 obese, 31 overweight, 20 nonobese) from a multiethnic, multiracial cohort

Comparison

Varying degrees of obesity (exposure) vs Nonobese children and adolescents (n=20)

Design

Cross-sectional

Authors

RWRam WeissCincinnati Children's Hospital Medical CenterTBTania S. BurgertCincinnati Children's Hospital Medical Center
William V. Tamborlane
William V. TamborlaneYale University

Discussion

Loading...

Member takes

Overview

Supports monitoring for metabolic syndrome as obesity severity rises in youth; leaves open optimal intervention thresholds.

Key Points

  • To evaluate the impact of increasing obesity severity on metabolic syndrome prevalence and assess its association with insulin resistance, C-reactive protein, and adiponectin in youth.
  • Assessed 439 obese, 31 overweight, and 20 nonobese children and adolescents using a standard glucose-tolerance test alongside lipid, C-reactive protein, and adiponectin panels.
  • Calculated age- and sex-standardized body-mass index z scores and adjusted blood pressure, high-density lipoprotein cholesterol, and triglyceride levels for age and sex.
  • Metabolic syndrome prevalence reached 50 percent in severely obese youth, with each 0.5-unit increase in body-mass index z score increasing risk (odds ratio, 1.55; 95% CI, 1.16 to 2.08).
  • Each 1-unit increase in homeostatic model insulin resistance significantly increased metabolic syndrome odds (odds ratio, 1.12; 95% CI, 1.07 to 1.18; P for trend < 0.001).
  • Increasing obesity severity was directly associated with elevated C-reactive protein levels and reduced protective adiponectin concentrations.

Structured PICO

Does increasing severity of obesity increase the prevalence of the metabolic syndrome and adverse cardiovascular biomarkers in children and adolescents?

P
Population
490 children and adolescents (439 obese, 31 overweight, 20 nonobese) from a multiethnic, multiracial cohort
I
Intervention
Varying degrees of obesity (exposure)
C
Comparator
Nonobese children and adolescents (n=20)
O
Outcome
Prevalence of the metabolic syndrome and its relation to insulin resistance, C-reactive protein, and adiponectin levelssurrogate

The prevalence of metabolic syndrome and adverse cardiovascular biomarkers is high and increases with worsening obesity in children and adolescents.

Cite This Study

Weiss et al. (2004) studied this question.

synapsesocial.com/papers/6a7c8d4c0ee04b7d6bfaaf58https://doi.org/10.1056/nejmoa031049
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults1999 · 3,671 citations
  2. 2Adiponectin represents an independent cardiovascular risk factor predicting serum HDL‐cholesterol levels in type 2 diabetes2003 · 104 citations
  3. 3Association of Hypoadiponectinemia With Coronary Artery Disease in Men2003 · 1,430 citations
  4. 4Long-Term Morbidity and Mortality of Overweight Adolescents1992 · 2,253 citations
  5. 5Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.1998 · 847 citations